èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ããHOOKIPA Pharma Inc.ã¯ãç¬èªã®ã¢ã¬ããŠã€ã«ã¹ãã©ãããã©ãŒã ã«åºã¥ããŠãææçãšãããæšçãšããå
ç«çæ³è¬ãéçºããŠããŸããå瀟ã®äž»èŠãªææç補ååè£ã¯HB-101ã§ããµã€ãã¡ã¬ããŠã€ã«ã¹éœæ§ãããŒããã®è
èç§»æ€ãåŸ
ã€æ£è
ã察象ã«ãã©ã³ãã åäºéç²æ€ç¬¬IIçžèšåºè©Šéšãè¡ãããŠããŸããå瀟ã®äž»èŠãªè
«ç補ååè£ã¯ãããããããŒããŠã€ã«ã¹16éœæ§ããã®æ²»çãç®çãšãã第I/IIçžèšåºè©Šéšäžã®HB-201ãšHB-202ã§ããå瀟ã¯ãæ
¢æ§BåèçãŠã€ã«ã¹ããã³ããå
ç«äžå
šãŠã€ã«ã¹ææçã®æ©èœçæ²»çããµããŒãããããšãç®çãšããææç補ååè£ã®éçºã§ãã®ãªã¢ãã»ãµã€ãšã³ã·ãºç€ŸãšææºããŠããŸããHOOKIPA Pharma Inc.ã¯2011幎ã«èšç«ããããã¥ãŒãšãŒã¯å·ãã¥ãŒãšãŒã¯ã«æ¬ç€Ÿã眮ããŠããŸãã